Article

Dr. Scott Gottlieb On the Need for More Regulations in Government-Funded Studies

Dr. Scott Gottlieb, MD, Resident Fellow, American Enterprise Institute; Senior Advisor, Avalere, addresses the need for more regulations in government funded studies. He also discusses possible misleading conclusions due to incentives that attempt to demonstrate a certain outcome from a study.

Dr. Gottlieb states that conclusions of clinical studies can be over interpreted and results can be overstated when they are government financed. He addresses the need to set uniform standards in terms of how government funded studies will speak about results, and on how CER research is going to be done in the future.

Related Videos
Dr Chun Chao
Screenshot of an interview with Shaun McKenzie, MD
Brianna Rhue, OD, FAAO
Julie Rodman, OD, MS, FAAO
Nate Lighthizer, OD, FAAO
Lidia Schapira, MD, FASCO, professor of medicine at Stanford Medicine, medical oncologist, and director for the Stanford Cancer Institute and the Stanford Comprehensive Cancer Center
Mile Brujic, OD, FAAO
Tiffany Meng, PharmD, oncology pharmacist, UCSF Health
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo